Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Paruzzo

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The Lancet. Haematology|March 16, 2025
CAR T-cell therapy in LMICs: approval of talicabtagene autoleucel in IndiaLuca Paruzzo, Marco Ruella
Cancer Treatment Reviews|August 7, 2022
Treatment strategies for patients with diffuse large B-cell lymphomaStefano Poletto, Mattia Novo, Luca Paruzzo, et al.
Cancers|January 11, 2024
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future PerspectiveStefano Poletto, Luca Paruzzo, Alessandro Nepote, et al.
Blood Cancer Discovery|June 21, 2024
Recent Advances in Immune-Based Therapies for Acute Myeloid LeukemiaCecilia Restelli, Marco Ruella, Luca Paruzzo, et al.
Blood Reviews|December 25, 2025
CAR-T for all? Barriers, facilitators, and interventions to commercial CAR T-cell therapy accessSofia Kaparis, Khashayar Eshaghi, Luca Paruzzo, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Extramedullary Multiple Myeloma: Challenges and OpportunitiesMatthew Ho, Luca Paruzzo, Janna Minehart, et al.
Molecular Therapy. Oncology|July 11, 2026
CART-immune-related adverse events after BCMA CAR-T therapyLuca Paruzzo, Matthew Ho, Julia Han Noll, et al.
Journal for Immunotherapy of Cancer|April 13, 2023
Apoptosis: a <i>Janus bifrons</i> in T-cell immunotherapyYong Gu Lee, Nicholas Yang, Inkook Chun, et al.
Cancers|June 25, 2020
Melanoma Brain Metastases in the Era of Target Therapies: An OverviewPaolo Becco, Susanna Gallo, Stefano Poletto, et al.
Journal of Clinical Medicine|February 15, 2022
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous MelanomaAlessandro Nepote, Gianluca Avallone, Simone Ribero, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The Lancet. Haematology|March 16, 2025
CAR T-cell therapy in LMICs: approval of talicabtagene autoleucel in IndiaLuca Paruzzo, Marco Ruella
Cancer Treatment Reviews|August 7, 2022
Treatment strategies for patients with diffuse large B-cell lymphomaStefano Poletto, Mattia Novo, Luca Paruzzo, et al.
Cancers|January 11, 2024
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future PerspectiveStefano Poletto, Luca Paruzzo, Alessandro Nepote, et al.
Blood Cancer Discovery|June 21, 2024
Recent Advances in Immune-Based Therapies for Acute Myeloid LeukemiaCecilia Restelli, Marco Ruella, Luca Paruzzo, et al.
Blood Reviews|December 25, 2025
CAR-T for all? Barriers, facilitators, and interventions to commercial CAR T-cell therapy accessSofia Kaparis, Khashayar Eshaghi, Luca Paruzzo, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Extramedullary Multiple Myeloma: Challenges and OpportunitiesMatthew Ho, Luca Paruzzo, Janna Minehart, et al.
Molecular Therapy. Oncology|July 11, 2026
CART-immune-related adverse events after BCMA CAR-T therapyLuca Paruzzo, Matthew Ho, Julia Han Noll, et al.
Journal for Immunotherapy of Cancer|April 13, 2023
Apoptosis: a <i>Janus bifrons</i> in T-cell immunotherapyYong Gu Lee, Nicholas Yang, Inkook Chun, et al.
Cancers|June 25, 2020
Melanoma Brain Metastases in the Era of Target Therapies: An OverviewPaolo Becco, Susanna Gallo, Stefano Poletto, et al.
Journal of Clinical Medicine|February 15, 2022
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous MelanomaAlessandro Nepote, Gianluca Avallone, Simone Ribero, et al.
Pageof 5